Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00994578 · ClinicalTrials.gov registry record · NA

Intervention Study of Communication in Oncologist-Patient Encounters

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
659
Enrollment target

NCT00994578: Completed NA study, sponsored by Duke University.

NCT00994578 is a NA study that has completed, run by Duke University. The registered enrollment target is 659 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00994578, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
659 participants
Enrollment target

Study Summary

The overall goal of this study is to improve communication between patients with advanced cancer and their oncologists. A web-based communication intervention will be delivered to patients to help them to express their negative emotions and elicit empathic responses from their oncologists. The specific aims are to: AIM 1: Develop a web-based intervention that trains patients with advanced cancer to express their emotional concerns to their oncologists and to request emotional support during clinical encounters. AIM 2: Test whether this intervention can increase patient expression of emotional concerns and requests for emotional support, as well as improve patient affect by decreasing negative emotions.

Interventions

  • BEHAVIORAL CHESS
  • BEHAVIORAL COPE
  • BEHAVIORAL CHESS/COPE

Trial Details

FieldValue
Enrollment Target 659 participants
Start Date 2010-11
Est. Completion 2014-04
Phase NA
Duke University

1,725 total trials

What the finished NCT00994578 record still lists

NCT00994578 is an interventional study that assigns participants to a tested intervention. The registered 659 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).

The record links to 0 conditions, and to 3 interventions - of which CHESS is the first listed.

NCT00994578 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00994578 about?

NCT00994578 is a clinical study titled "Intervention Study of Communication in Oncologist-Patient Encounters". The overall goal of this study is to improve communication between patients with advanced cancer and their oncologists. A web-based communication intervention will be delivered to patients to help them to express their negative emotions and elicit empathic responses from their oncologists. The spec...

What is the current status of trial NCT00994578?

This trial is currently completed. It is a NA study. The enrollment target is 659 participants. The study started on 2010-11. Estimated completion is 2014-04.

What interventions are being tested in trial NCT00994578?

The interventions under investigation include: CHESS (BEHAVIORAL), COPE (BEHAVIORAL), CHESS/COPE (BEHAVIORAL).

Who is sponsoring clinical trial NCT00994578?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00994578's enrollment target sits among peer trials

659 156th of 2000 higher than 1,845 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07216742 · 659 participants · Phase 3

    Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

  • NCT01185132 · 660 participants · Phase 3

    Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

  • NCT03346694 · 660 participants · NA

    Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing

  • NCT05407636 · 660 participants · Phase 3

    Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00994578, the US trial registry maintained by the National Library of Medicine. NCT00994578 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.